Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

50.650
+0.1500.30%
Volume:33.03M
Turnover:1.68B
Market Cap:209.94B
PE:37.47
High:52.000
Open:50.500
Low:50.100
Close:50.500
52wk High:54.450
52wk Low:28.480
Shares:4.15B
HK Float Shares:4.15B
Volume Ratio:0.59
T/O Rate:0.80%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.352
ROE:11.38%
ROA:7.60%
PB:3.75
PE(LYR):37.47
PS:7.63

Loading ...

Earning Preview: WUXI BIO this quarter’s revenue is expected to increase by 0%, and institutional views are bullish

Earnings Agent
·
Aug 18

Wuxi Biologics (Cayman) Stock Rises 2.3% in Hong Kong

Dow Jones
·
Aug 17

WuXi Biologics Agrees to Sell 51.1% Stake in Bestchrom

Reuters
·
Aug 17

HK Movers | Pharma Stocks Gain With HUTCHMED up 8%, JOINN up 6%

Tiger Newspress
·
Aug 17

Movement Alert|WUXI BIO Rises 3.5% in Regular Trading, CXO Sector Upswing and Strategic Asset Disposal Boost Sentiment

Market Focus
·
Aug 17

Everest Medicines Appoints Yue Wang as Non-Executive Director

Reuters
·
Aug 14

Wuxi Biologics (Cayman) Stock Sheds 1.3% in Hong Kong

Dow Jones
·
Aug 14

Akari Net Loss Widens to $4.81 Million in Q2 FY26; Operating Loss Rises to $4.6 Million

Reuters
·
Aug 14

Bank of America Securities Raises Targets for Chinese CXO Firms on Strong Biotech Funding

Stock News
·
Aug 13

HK Movers | Hong Kong Biotech Stocks Rally; Genscript Bio Jumps Over 7%, Zai Lab Gains Over 6%

Tiger Newspress
·
Aug 11

Movement Alert|WUXI BIO Rises 3.08% in Regular Trading, CXO Sector Recovery Signals Strengthened by Peer Earnings Beat and Acquisition Expansion

Market Focus
·
Aug 11

CRO Sector Surges as Wuxi Apptec Secures US Court Injunction, Suspending Defense Department Listing

Stock News
·
Aug 10

HK Movers | Pharma Stocks Jump With Viva Biotech up 15%, WuXi XDC, WuXi Biologics up 6%

Tiger Newspress
·
Aug 10

Stock Track | WUXI BIO Soars 5.10% Intraday on Acquisition Deal and Sector Tailwinds

Stock Track
·
Aug 10

Movement Alert|WUXI BIO Rises 4.75% in Regular Trading, CXO Sector Momentum Continues Amid Acquisition and Earnings Catalysts

Market Focus
·
Aug 10

Biotech ETF Gains Over 5% as Leading Innovators Report Strong Earnings and Global Supply Chain Remains Robust

Stock News
·
Aug 07

Hong Kong Market Movers: Innovative Drug Stocks Rally as Earnings Season Approaches, Medical Conferences Expected to Provide Catalysts

Stock News
·
Aug 07

WuXi Bio Co., Ltd. gains nearly 6% in early trading, plans to acquire ChuangSheng Pharma's process development and manufacturing base in Hangzhou

Deep News
·
Aug 07

Movement Alert|WUXI BIO Rises 3.19% in Regular Trading, CXO Sector Rallies on Strong Peer Earnings and Upcoming Interim Results

Market Focus
·
Aug 07

Transcenta Agrees to Sell CDMO Assets to WuXi Biologics Unit for RMB 190 Million

Reuters
·
Aug 07